Results 241 to 250 of about 881,500 (386)

Superiority of the Rockwood Clinical Frailty Scale for Assessing Long‐Term Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Frailty is associated with poorer short‐term outcomes after transcatheter aortic valve implantation (TAVI), and national guidelines recommend an assessment of frailty as part of the decision‐making process. However, multiple frailty indices are currently used in clinical practice, and it is unclear which has the best discrimination ...
Timothy J. Bagnall, Arul Baradi, Christopher Pavitt, Huda Abu‐Own, Andrew Hill, Stanislav Hadjivassilev, Jessica Parker, Victoria Parish, Michael Michail, James Cockburn, David Hildick‐Smith, Christopher J. Broyd   +11 more
wiley   +1 more source

Instruments Used to Assess Health-Related Quality of Life in Valvular Heart Disease: A Narrative Review. [PDF]

Cureus
Marinescu AD, Costache VS.
europepmc   +1 more source

Cardiovascular Effects of Nalbuphine in Patients with Coronary or Valvular Heart Disease [PDF]

, 1982
Carol L. Lake, Elizabeth N. Duckworth, Cosmo A. DiFazio, Charles G. Durbin, Michael R. Magruder   +4 more
openalex   +1 more source

Incidence and Predictors of Hypoattenuated Thickening and Device‐Related Thrombus at Three Months Postprocedural CT Assessment Following Left Atrial Appendage Occlusion With Amplatzer Devices—A Single‐Center Cohort

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Left atrial appendage occlusion (LAAO) has become a valuable alternative to long‐term anticoagulation for stroke prevention in patients with non‐valvular atrial fibrillation (AF), especially in those at high bleeding risk. Hypoattenuated thickening (HAT) and device‐related thrombus (DRT) remain notable postprocedural concerns ...
Pierre Guilleminot, Carole Richard, Antoine Roger, Marlène Daller, Gabriel Laurent, Catherine Vergely, Charles Guenancia, Thibaut Pommier   +7 more
wiley   +1 more source

Accelerated biological aging and incident degenerative valvular heart disease: Findings from 408,783 UK Biobank participants. [PDF]

Int J Cardiol Heart Vasc
Lin C, Wei E, Lai Q, Jiang H, Lin M, Hu F, Fan L, Yao E.   +7 more
europepmc   +1 more source

Systolic Time Intervals in Valvular Heart Disease

, 1980
Youngjoo Kwon, Kil Yang Lee, Il Bong Kim, Dae Whan Kim, Yong Hwan Choi, Hi Myung Park   +5 more
openalex   +1 more source

Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) has gained interest as concomitant coronary artery disease (CAD) is now often treated conservatively before TAVR, and TAVR is increasingly used in younger patients with longer life expectancies. Therefore, more contemporary data on PCI after
Hugo M. Aarts, Kimberley I. Hemelrijk, Gijs M. Broeze, Steven A. Muller, Lineke Derks, Ronak Delewi, Michiel Voskuil, the Transcatheter Heart Intervention and Percutaneous Coronary Intervention registration committees of the Netherlands Heart Registration   +7 more
wiley   +1 more source

Epidemiology of Valvular Heart Disease in Asia Pacific Region. [PDF]

JACC Asia
So KC, Yap J, Song GY, Poon K, Sung SH, Chandavimol M, Hayashida K, Park DW, Ewe SH, Chen M, Hei-Tung Chan V, Iwata J, Tangcharoen T, Tern P, Park HS, Alasnag M, Ohno Y, Hon JKF, Bhagwandeen R, Tabata M, Lee AP, Jilaihawi H, Wang DD, Tang GHL, Lim DS, Modine T, Lam YY.   +26 more
europepmc   +1 more source

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Determination of Induction Time in Adult Patients with Valvular Heart Disease. [PDF]

Indian Heart J
Mital T, Hasija S, Das S, Chauhan S, Khan MA.   +4 more
europepmc   +1 more source